Guilin Layn Natural Ingredients002166.SZValuation Analysis

As of Oct 19, 2026, Guilin Layn Natural Ingredients (002166.SZ) trades at a P/E of 30.80x, P/B of 1.60x, P/S of 2.85x, and a dividend yield of 1.46%.
Longitudinal percentile comparison: P/E sits at the 11th percentile over the trailing 10Y window (vs. 4th percentile over 3Y); P/B sits at the 3rd percentile over the trailing 10Y window (vs. 10th percentile over 3Y); P/S sits at the 3rd percentile over the trailing 10Y window (vs. 9th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 42nd percentile within its industry and the 43rd percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 2.38%, ranking at the 94th percentile over the trailing 20Y window.
The P/E and P/B long-window percentiles differ by only 8.1 points, pointing to a consistent valuation read across both metrics. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Breaking down the total shareholder yield: 1.46% comes from cash dividends, with an implied ~0.92% from buybacks — a fairly balanced mix of both channels. Guilin Layn Natural Ingredients operates in the Medicine sector. Data refreshes weekly and is for reference only, not investment advice.